Startup Intrexon Closes $1M VC Round to Develop Tools to Uncover Location of Sub-Cellular Events | GenomeWeb

"Location, location, location" is a real estate adage, but it could also be the buzzwords of nascent biological reagent provider Intrexon, which this week said it closed a $1 million round of private equity financing to help develop and market its line of location-dependent sub-cellular genetic tools.

Intrexon's technology is based on the theory that knowing the location of sub-cellular events may determine a distinct phenotype, a notion that the company believes is growing among researchers. As the company's CEO puts it, "location matters."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.